Papaioannou A, Loukides S, Vassilakopoulos T, Tzanakis N, Kostikas K, Hillas G
Int J Chron Obstruct Pulmon Dis. 2025; 20:457-471.
PMID: 40041472
PMC: 11878287.
DOI: 10.2147/COPD.S481337.
Casadevall C, Quero S, Millares L, Faner R, Cosio B, Peces-Barba G
Int J Mol Sci. 2024; 25(15).
PMID: 39126034
PMC: 11313397.
DOI: 10.3390/ijms25158467.
Pignatti P, Visca D, Zappa M, Zampogna E, Saderi L, Sotgiu G
BMC Pulm Med. 2024; 24(1):247.
PMID: 38764008
PMC: 11102620.
DOI: 10.1186/s12890-024-03062-1.
Li J, Zuo Y, Feng L, Samuel Cai Y, Su J, Tong Z
BMJ Open Respir Res. 2024; 11(1).
PMID: 38609180
PMC: 11029211.
DOI: 10.1136/bmjresp-2023-001634.
Feng L, Li J, Qian Z, Li C, Gao D, Wang Y
J Inflamm Res. 2024; 17:1511-1526.
PMID: 38476472
PMC: 10929658.
DOI: 10.2147/JIR.S450447.
Blood Eosinophil Count and Its Determinants in a Chinese Population-Based Cohort.
Yang M, Lv Y, Tang S, Xu D, Li D, Liao Z
Respiration. 2024; 103(2):70-78.
PMID: 38253034
PMC: 10871690.
DOI: 10.1159/000535989.
Predictive Role of White Blood Cell Differential Count for the Development of Acute Exacerbation in Korean Chronic Obstructive Pulmonary Disease.
Yoon E, Koo S, Park H, Kim H, Kim W, Kim K
Int J Chron Obstruct Pulmon Dis. 2024; 19:17-31.
PMID: 38192972
PMC: 10773455.
DOI: 10.2147/COPD.S435921.
Rational use of inhaled corticosteroids for the treatment of COPD.
Quint J, Ariel A, Barnes P
NPJ Prim Care Respir Med. 2023; 33(1):27.
PMID: 37488104
PMC: 10366209.
DOI: 10.1038/s41533-023-00347-6.
Clinical Characteristics and Outcome Related to Blood Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) Patients.
Albanna A, Almuyidi F, Beitar N, Alshumrani A, Al Nufaiei Z, Khayat R
Cureus. 2022; 14(8):e27998.
PMID: 36134112
PMC: 9469908.
DOI: 10.7759/cureus.27998.
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy.
Chen S, Miravitlles M, Rhee C, Pavord I, Jones R, Carter V
Int J Chron Obstruct Pulmon Dis. 2022; 17:2187-2200.
PMID: 36110306
PMC: 9470244.
DOI: 10.2147/COPD.S378649.
COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.
Pace W, Brandt E, Carter V, Chang K, Edwards C, Evans A
Ann Fam Med. 2022; 20(4):319-327.
PMID: 35879087
PMC: 9328699.
DOI: 10.1370/afm.2829.
Immunophenotyping of Acute Inflammatory Exacerbations of Lung Injury Driven by Mutant Surfactant Protein-C: A Role for Inflammatory Eosinophils.
Nguyen J, Armstrong B, Cowman S, Tomer Y, Veerabhadraiah S, Beers M
Front Pharmacol. 2022; 13:875887.
PMID: 35571100
PMC: 9094740.
DOI: 10.3389/fphar.2022.875887.
Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma.
Li A, Chan H, Gan P, Liew M, Wong W, Lim H
Korean J Intern Med. 2021; 36(6):1305-1319.
PMID: 34634855
PMC: 8588979.
DOI: 10.3904/kjim.2021.180.
Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.
Acet-Ozturk N, Dilektasli A, Aydin-Guclu O, Demirdogen E, Coskun F, Ursavas A
Clin Respir J. 2021; 16(1):49-56.
PMID: 34626077
PMC: 9060034.
DOI: 10.1111/crj.13451.
Clinical Predictors of High Blood Eosinophils in Chronic Obstructive Pulmonary Disease.
Yang M, Yang T, Li X, Li D, Liao Z, Shen Y
Int J Chron Obstruct Pulmon Dis. 2021; 16:2467-2474.
PMID: 34483658
PMC: 8409512.
DOI: 10.2147/COPD.S324511.
Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Liu T, Xiang Z, Hou X, Chai J, Yang Y, Zhang X
Ther Adv Chronic Dis. 2021; 12:20406223211028768.
PMID: 34285789
PMC: 8267047.
DOI: 10.1177/20406223211028768.
Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
Benson V, Hartl S, Barnes N, Galwey N, Van Dyke M, Kwon N
Eur Respir J. 2021; 59(1).
PMID: 34172466
PMC: 8756293.
DOI: 10.1183/13993003.04590-2020.
Blood eosinophil count predicts treatment failure and hospital readmission for COPD.
Kerkhof M, Chaudhry I, Pavord I, Miravitlles M, Rhee C, Halpin D
ERJ Open Res. 2021; 6(4).
PMID: 33693048
PMC: 7927786.
DOI: 10.1183/23120541.00188-2020.
The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
Kang H, Kim S, Kim Y, Kim J, Lee S, Yoon H
BMC Pulm Med. 2021; 21(1):74.
PMID: 33653314
PMC: 7923497.
DOI: 10.1186/s12890-021-01443-4.
Association Between Blood Eosinophils and Mortality in Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.
Yang J, Yang J
Int J Chron Obstruct Pulmon Dis. 2021; 16:281-288.
PMID: 33603354
PMC: 7887152.
DOI: 10.2147/COPD.S289920.
